Clinical effectiveness analysis of kidney-sparing surgery for treatment of primary ureteral cancer

Mingqiu HU,Ningchen LI,Zhihong ZHANG,Shihua JIN,Hongfeng GUO,Yi WANG,Xianghua ZHANG,Yanqun NA
DOI: https://doi.org/10.13201/j.issn.1001-1420.2017.11.011
2017-01-01
Journal of Clinical Urology
Abstract:Objective:To explore and analyse the tumour outcome of primary ureteral cancer treated by kidneysparing surgery.Method:The cases of primary ureteral cancer from January 2007 to December 2015 in Peking University Shougang Hospital were reviewed and analyzed.Of 12 cases of primary ureteral cancer treated by kidneysparing surgery,11 cases were found unifocal,one was found bilateral,12 were found distal ureter and one was found middle ureter.The distal ureterectomy plus bladder cuff excision and ureteral neocystostomy were performed in five cases.Ureteroscopic ablation with holmium laser conducted in five cases.One case was performed with segmental ureterectomy and ureteroureteral anastomsis.One patient with bilateral ureteral tumor synchronically was carried out by removing bilateral distal ureter and cutaneous ureterostomy.All the cases were indwelt with ureteral stent tube,and the tube was removed four weeks postoperatively.Of them,nine cases were performed with cystic irrigation.Result:All of them were urothelial carcinoma.Except one withdraw,11 cases were followed up from 3 to 108 months with the mean of (48.08±32.75) months.The total recurrence rate was 54.55% (6/11),while the average cancer-free survival was (24.2±19.46) months.The incidence of bladder cancer within two years postoperatively was 9.0%.The two-year overall survival was 81.81% (9/11) and five-year overall survival was 54.54% (6/11).Conclusion:The kidney-sparing surgery treating primary ureteral cancer is safe,feasible and effective.However,the strict surveillance and follow-up should be conducted in the patients after operation,including ureteroscopic exam.
What problem does this paper attempt to address?